Sofosbuvir as treatment against dengue?
Dengvaxia® (CTD-TDV), the only licensed tetravalent dengue vaccine by Sanofi Pasteur, was made available since 2015. However, administration of CTD-TDV, in general, has not received the prequalification recommendation from the World Health Organization. Having a universal antidengue agent for treatm...
Saved in:
Main Authors: | Gan, Chye Sheng, Lim, See Khai, Chee, Chin Fei, Yusof, Rohana, Heh, Choon Han |
---|---|
Format: | Article |
Published: |
Wiley
2017
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/22051/ https://doi.org/10.1111/cbdd.13091 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rational discovery of dengue type 2 non-competitive inhibitors / Heh Choon Han
by: Heh, Choon Han
Published: (2012) -
Discovery of dengue virus inhibitors
by: Abdullah, Adib Afandi, et al.
Published: (2020) -
Fresh drive against dengue
by: New Sunday Times, Malaysia
Published: (1983) -
Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population.
by: Appanna, R., et al.
Published: (2010) -
Rational drug discovery: Ellagic acid as a potent dual-target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes
by: Lim, See Khai, et al.
Published: (2021)